ProQR Therapeutics N.V. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for PRQR, updated each market day.
PRQR AI Sentiment
AI predicts ProQR Therapeutics N.V. Ordinary Shares stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About ProQR Therapeutics N.V. Ordinary Shares
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Exchange
Market Cap
$266,714,970
Cap Tier
Employees
187
Listed Since
Sept. 18, 2014
Website
PRQR Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PRQR Volatility
ProQR Therapeutics N.V. Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
